1. Home
  2. NVAX vs DNUT Comparison

NVAX vs DNUT Comparison

Compare NVAX & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • DNUT
  • Stock Information
  • Founded
  • NVAX 1987
  • DNUT 1937
  • Country
  • NVAX United States
  • DNUT United States
  • Employees
  • NVAX N/A
  • DNUT N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • DNUT Food Chains
  • Sector
  • NVAX Health Care
  • DNUT Consumer Staples
  • Exchange
  • NVAX Nasdaq
  • DNUT Nasdaq
  • Market Cap
  • NVAX 2.0B
  • DNUT 1.9B
  • IPO Year
  • NVAX 1995
  • DNUT 2021
  • Fundamental
  • Price
  • NVAX $9.76
  • DNUT $11.35
  • Analyst Decision
  • NVAX Buy
  • DNUT Buy
  • Analyst Count
  • NVAX 6
  • DNUT 9
  • Target Price
  • NVAX $17.83
  • DNUT $15.56
  • AVG Volume (30 Days)
  • NVAX 7.2M
  • DNUT 1.1M
  • Earning Date
  • NVAX 11-07-2024
  • DNUT 11-07-2024
  • Dividend Yield
  • NVAX N/A
  • DNUT 1.22%
  • EPS Growth
  • NVAX N/A
  • DNUT N/A
  • EPS
  • NVAX N/A
  • DNUT N/A
  • Revenue
  • NVAX $987,667,000.00
  • DNUT $1,739,779,000.00
  • Revenue This Year
  • NVAX N/A
  • DNUT $2.13
  • Revenue Next Year
  • NVAX N/A
  • DNUT $7.84
  • P/E Ratio
  • NVAX N/A
  • DNUT N/A
  • Revenue Growth
  • NVAX N/A
  • DNUT 8.06
  • 52 Week Low
  • NVAX $3.53
  • DNUT $9.18
  • 52 Week High
  • NVAX $23.86
  • DNUT $17.84
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 36.20
  • DNUT 56.23
  • Support Level
  • NVAX $9.52
  • DNUT $11.46
  • Resistance Level
  • NVAX $10.63
  • DNUT $11.82
  • Average True Range (ATR)
  • NVAX 0.57
  • DNUT 0.29
  • MACD
  • NVAX -0.12
  • DNUT 0.04
  • Stochastic Oscillator
  • NVAX 9.97
  • DNUT 81.12

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

About DNUT Krispy Kreme Inc.

Krispy Kreme Inc is a sweet treat brands company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in- your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing ecommerce and delivery business. The company conducts its business through the following three reported segments namely U.S., includes all operations in the U.S. and Canada, Insomnia Cookies shops, and the Branded Sweet Treat Line; International includes operations in the U.K., Ireland, Australia, New Zealand, and Mexico; and Market Development includes franchise operations across the globe, as well as operations in Japan. It derives maximum revenue from U.S. Segment.

Share on Social Networks: